Announced Thu, 26 Jun · 19:49 IST

Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Entero Healthcare Solutions has informed the stock exchanges about an upcoming group meeting with analysts and institutional investors scheduled for 2nd July 2025, starting at 3:00 PM in a virtual format. The company has clarified that the discussions will be limited to publicly available information and no unpublished price-sensitive information (UPSI) will be shared. This disclosure is being made under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The intimation was signed by Sanu Kapoor, Vice President, General Counsel, and Company Secretary. This is a routine compliance filing with no new business or financial details being communicated.

Likely market impact

This is a standard regulatory disclosure with no material impact on the stock, as the company has confirmed no price-sensitive information will be discussed. Investors should not expect any immediate catalyst from this meeting.